CARI JOHNSON: Open Payments
NPI 1811338858 · LEITCHFIELD, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,110 in 76 payments from 15 companies in 2025. Trend: 2023 $854 · 2024 $896 · 2025 $1,110
Food & beverage: $1,110
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 20 | $350 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 13 | $162 |
| ABBVIE INC. | 17 | $161 |
| Phathom Pharmaceuticals, Inc. | 5 | $84 |
| AstraZeneca Pharmaceuticals LP | 3 | $56 |
| Amgen Inc. | 3 | $53 |
| Lilly USA, LLC | 3 | $52 |
| Axsome Therapeutics, Inc. | 2 | $34 |
| Verona Pharma, Inc. | 2 | $30 |
| Exact Sciences Corporation | 2 | $29 |
Products named: Ozempic, CAPLYTA, VOQUEZNA, Rybelsus, VRAYLAR, Wegovy, MOUNJARO, UBRELVY.
Industry payments across KY — which companies pay providers there.
